The effect of racemic gossypol and AT-101 on angiogenic profile of OVCAR-3 cells: a preliminary molecular framework for gossypol enantiomers
To compare the effect of racemic gossypol with its (–)/(–) enantiomer (AT-101) on expression profiles of angiogenic molecules by mRNA levels in human ovarian cancer cell line OVCAR-3. Methods: Cell viability assay (2,3-bis (2-methoxy-4-nitro-5- sulfophenyl)-5-[(phenylamino) carbonyl]-2H-tetrazolium...
Збережено в:
Дата: | 2009 |
---|---|
Автори: | , , , , , , , , , , |
Формат: | Стаття |
Мова: | English |
Опубліковано: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2009
|
Назва видання: | Experimental Oncology |
Теми: | |
Онлайн доступ: | http://dspace.nbuv.gov.ua/handle/123456789/138141 |
Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
Назва журналу: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
Цитувати: | The effect of racemic gossypol and AT-101 on angiogenic profile of OVCAR-3 cells: a preliminary molecular framework for gossypol enantiomers / U. Varol, B. Karaca, D. Tunali, M. Degirmenci, Y. Cirak, D.U. Purcu, S. Uzunolgu, C. Sezgin, B. Karabulut, U.A. Sanli, R. Uslu // Experimental Oncology. — 2009. — Т. 31, № 4. — С. 220-225. — Бібліогр.: 34 назв. — англ. |
Репозитарії
Digital Library of Periodicals of National Academy of Sciences of Ukraineid |
irk-123456789-138141 |
---|---|
record_format |
dspace |
spelling |
irk-123456789-1381412018-06-19T03:03:34Z The effect of racemic gossypol and AT-101 on angiogenic profile of OVCAR-3 cells: a preliminary molecular framework for gossypol enantiomers Varol, U. Karaca, B. Tunali, D. Degirmenci, M. Cirak, Y. Purcu, D.U. Uzunoglu, S. Sezgin, C. Karabulut, B. Sanli, U.A. Uslu, R. Original contributions To compare the effect of racemic gossypol with its (–)/(–) enantiomer (AT-101) on expression profiles of angiogenic molecules by mRNA levels in human ovarian cancer cell line OVCAR-3. Methods: Cell viability assay (2,3-bis (2-methoxy-4-nitro-5- sulfophenyl)-5-[(phenylamino) carbonyl]-2H-tetrazolium hydroxide) was used to detect cytotoxicity of gossypol enantiomers. DNA fragmentation by an enzyme-linked immunosorbent (ELISA) assay was used to evaluate the rate of apoptosis. The mRNA expression levels of angiogenic molecules were investigated by Human Angiogenesis RT2 ProfilerTM PCR Array (SuperArray, Frederick, MD). Results: Both racemic form and AT-101 resulted in a significant cytotoxicity and induced apoptosis. This effect was observed in a dose- and time dependent manner. However, AT-101 was much more potent. In addition, the treatment of 10 μM of racemic gossypol alone and 3 μM of AT-101 alone resulted in significant down-regulation (≥ 3 fold) in mRNA levels of some pivotal angiogenic molecules in OVCAR-3, but altered gene profiles were different by the treatment of each enantiomer. Conclusion: The efficacy of two gossypol enantiomers in OVCAR-3 cells showed distinction. AT-101 was much more potent than racemic gossypol, not only by means of cell death and apoptosis, but also by modulation of angiogenic molecules released from OVCAR-3 cells. Further studies with endothelial cells should be done to verify the anti-angiogenic effect of gossypol enantiomers in cancer treatment. 2009 Article The effect of racemic gossypol and AT-101 on angiogenic profile of OVCAR-3 cells: a preliminary molecular framework for gossypol enantiomers / U. Varol, B. Karaca, D. Tunali, M. Degirmenci, Y. Cirak, D.U. Purcu, S. Uzunolgu, C. Sezgin, B. Karabulut, U.A. Sanli, R. Uslu // Experimental Oncology. — 2009. — Т. 31, № 4. — С. 220-225. — Бібліогр.: 34 назв. — англ. 1812-9269 http://dspace.nbuv.gov.ua/handle/123456789/138141 en Experimental Oncology Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України |
institution |
Digital Library of Periodicals of National Academy of Sciences of Ukraine |
collection |
DSpace DC |
language |
English |
topic |
Original contributions Original contributions |
spellingShingle |
Original contributions Original contributions Varol, U. Karaca, B. Tunali, D. Degirmenci, M. Cirak, Y. Purcu, D.U. Uzunoglu, S. Sezgin, C. Karabulut, B. Sanli, U.A. Uslu, R. The effect of racemic gossypol and AT-101 on angiogenic profile of OVCAR-3 cells: a preliminary molecular framework for gossypol enantiomers Experimental Oncology |
description |
To compare the effect of racemic gossypol with its (–)/(–) enantiomer (AT-101) on expression profiles of angiogenic molecules by mRNA levels in human ovarian cancer cell line OVCAR-3. Methods: Cell viability assay (2,3-bis (2-methoxy-4-nitro-5- sulfophenyl)-5-[(phenylamino) carbonyl]-2H-tetrazolium hydroxide) was used to detect cytotoxicity of gossypol enantiomers. DNA fragmentation by an enzyme-linked immunosorbent (ELISA) assay was used to evaluate the rate of apoptosis. The mRNA expression levels of angiogenic molecules were investigated by Human Angiogenesis RT2 ProfilerTM PCR Array (SuperArray, Frederick, MD). Results: Both racemic form and AT-101 resulted in a significant cytotoxicity and induced apoptosis. This effect was observed in a dose- and time dependent manner. However, AT-101 was much more potent. In addition, the treatment of 10 μM of racemic gossypol alone and 3 μM of AT-101 alone resulted in significant down-regulation (≥ 3 fold) in mRNA levels of some pivotal angiogenic molecules in OVCAR-3, but altered gene profiles were different by the treatment of each enantiomer. Conclusion: The efficacy of two gossypol enantiomers in OVCAR-3 cells showed distinction. AT-101 was much more potent than racemic gossypol, not only by means of cell death and apoptosis, but also by modulation of angiogenic molecules released from OVCAR-3 cells. Further studies with endothelial cells should be done to verify the anti-angiogenic effect of gossypol enantiomers in cancer treatment. |
format |
Article |
author |
Varol, U. Karaca, B. Tunali, D. Degirmenci, M. Cirak, Y. Purcu, D.U. Uzunoglu, S. Sezgin, C. Karabulut, B. Sanli, U.A. Uslu, R. |
author_facet |
Varol, U. Karaca, B. Tunali, D. Degirmenci, M. Cirak, Y. Purcu, D.U. Uzunoglu, S. Sezgin, C. Karabulut, B. Sanli, U.A. Uslu, R. |
author_sort |
Varol, U. |
title |
The effect of racemic gossypol and AT-101 on angiogenic profile of OVCAR-3 cells: a preliminary molecular framework for gossypol enantiomers |
title_short |
The effect of racemic gossypol and AT-101 on angiogenic profile of OVCAR-3 cells: a preliminary molecular framework for gossypol enantiomers |
title_full |
The effect of racemic gossypol and AT-101 on angiogenic profile of OVCAR-3 cells: a preliminary molecular framework for gossypol enantiomers |
title_fullStr |
The effect of racemic gossypol and AT-101 on angiogenic profile of OVCAR-3 cells: a preliminary molecular framework for gossypol enantiomers |
title_full_unstemmed |
The effect of racemic gossypol and AT-101 on angiogenic profile of OVCAR-3 cells: a preliminary molecular framework for gossypol enantiomers |
title_sort |
effect of racemic gossypol and at-101 on angiogenic profile of ovcar-3 cells: a preliminary molecular framework for gossypol enantiomers |
publisher |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України |
publishDate |
2009 |
topic_facet |
Original contributions |
url |
http://dspace.nbuv.gov.ua/handle/123456789/138141 |
citation_txt |
The effect of racemic gossypol and AT-101 on angiogenic profile of OVCAR-3 cells: a preliminary molecular framework for gossypol enantiomers / U. Varol, B. Karaca, D. Tunali, M. Degirmenci, Y. Cirak, D.U. Purcu, S. Uzunolgu, C. Sezgin, B. Karabulut, U.A. Sanli, R. Uslu // Experimental Oncology. — 2009. — Т. 31, № 4. — С. 220-225. — Бібліогр.: 34 назв. — англ. |
series |
Experimental Oncology |
work_keys_str_mv |
AT varolu theeffectofracemicgossypolandat101onangiogenicprofileofovcar3cellsapreliminarymolecularframeworkforgossypolenantiomers AT karacab theeffectofracemicgossypolandat101onangiogenicprofileofovcar3cellsapreliminarymolecularframeworkforgossypolenantiomers AT tunalid theeffectofracemicgossypolandat101onangiogenicprofileofovcar3cellsapreliminarymolecularframeworkforgossypolenantiomers AT degirmencim theeffectofracemicgossypolandat101onangiogenicprofileofovcar3cellsapreliminarymolecularframeworkforgossypolenantiomers AT ciraky theeffectofracemicgossypolandat101onangiogenicprofileofovcar3cellsapreliminarymolecularframeworkforgossypolenantiomers AT purcudu theeffectofracemicgossypolandat101onangiogenicprofileofovcar3cellsapreliminarymolecularframeworkforgossypolenantiomers AT uzunoglus theeffectofracemicgossypolandat101onangiogenicprofileofovcar3cellsapreliminarymolecularframeworkforgossypolenantiomers AT sezginc theeffectofracemicgossypolandat101onangiogenicprofileofovcar3cellsapreliminarymolecularframeworkforgossypolenantiomers AT karabulutb theeffectofracemicgossypolandat101onangiogenicprofileofovcar3cellsapreliminarymolecularframeworkforgossypolenantiomers AT sanliua theeffectofracemicgossypolandat101onangiogenicprofileofovcar3cellsapreliminarymolecularframeworkforgossypolenantiomers AT uslur theeffectofracemicgossypolandat101onangiogenicprofileofovcar3cellsapreliminarymolecularframeworkforgossypolenantiomers AT varolu effectofracemicgossypolandat101onangiogenicprofileofovcar3cellsapreliminarymolecularframeworkforgossypolenantiomers AT karacab effectofracemicgossypolandat101onangiogenicprofileofovcar3cellsapreliminarymolecularframeworkforgossypolenantiomers AT tunalid effectofracemicgossypolandat101onangiogenicprofileofovcar3cellsapreliminarymolecularframeworkforgossypolenantiomers AT degirmencim effectofracemicgossypolandat101onangiogenicprofileofovcar3cellsapreliminarymolecularframeworkforgossypolenantiomers AT ciraky effectofracemicgossypolandat101onangiogenicprofileofovcar3cellsapreliminarymolecularframeworkforgossypolenantiomers AT purcudu effectofracemicgossypolandat101onangiogenicprofileofovcar3cellsapreliminarymolecularframeworkforgossypolenantiomers AT uzunoglus effectofracemicgossypolandat101onangiogenicprofileofovcar3cellsapreliminarymolecularframeworkforgossypolenantiomers AT sezginc effectofracemicgossypolandat101onangiogenicprofileofovcar3cellsapreliminarymolecularframeworkforgossypolenantiomers AT karabulutb effectofracemicgossypolandat101onangiogenicprofileofovcar3cellsapreliminarymolecularframeworkforgossypolenantiomers AT sanliua effectofracemicgossypolandat101onangiogenicprofileofovcar3cellsapreliminarymolecularframeworkforgossypolenantiomers AT uslur effectofracemicgossypolandat101onangiogenicprofileofovcar3cellsapreliminarymolecularframeworkforgossypolenantiomers |
first_indexed |
2023-10-18T21:17:32Z |
last_indexed |
2023-10-18T21:17:32Z |
_version_ |
1796152424045477888 |